News and Updates

The FDA is reviewing a new Lunsumio and Polivy combo for relapsed B-cell lymphoma. Discover how this dual-targeted therapy could transform patient outcomes.

The FDA has approved Utebzi, the first oral carbapenem for complicated UTIs. Learn how this breakthrough antibiotic is transforming outpatient clinical care.

A landmark clinical trial is testing senolytic drugs to clear aging "zombie cells." Discover how this could revitalize the immune system and fight aging.

New clinical findings reveal that daily postbiotic gummies can reduce gum bleeding in just six weeks, offering a promising new tool for oral health care.

Biogen confirms the acquisition of RayThera to expand its immunology pipeline. Discover how this strategic move strengthens its position in autoimmune therapy.

A new clinical trial is testing a fully implantable BCI for advanced ALS patients, aiming to restore communication through direct neural signal decoding.

The FDA has extended the public feedback period for its AI medical device pilot program, aiming to refine regulations for machine learning in healthcare.

Clinical AI often hits a performance wall in real-world hospitals. Discover the core challenges of data bias and integration, and how to fix them for success.

In a milestone for medicine, a drug designed by AI has entered human trials. Discover how this innovative approach could change Parkinson's treatment.

UniQure is set to re-engage the FDA for its Huntington’s disease gene therapy, aiming to overcome previous regulatory hurdles with new clinical data.